Brainomix and Bridge Biotherapeutics, Inc. Announce Partnership to Utilize Brainomix' AI-Powered e-ILD Software for Automated Assessment of Idiopathic Pulmonary Fibrosis (IPF)

/PRNewswire/ -- Brainomix, the AI-powered medtech solutions company, and Bridge Biotherapeutics, Inc., a South Korean clinical-stage biotechnology company...

Related Keywords

China ,South Korea ,South Korean ,Republic Of Korea ,Peter George ,Prnewswire Brainomix ,Jeff Wyrtzen ,Agnes Jung ,Sue Charles ,Brainomix Biotherapeutics ,Tencent Holdings ,Oxford University Innovation Fund ,Biotherapeutics Inc ,University Of Oxford ,Marketing Business Development ,Boehringer Ingelheim Venture Fund ,Bridge Biotherapeutics Inc ,Idiopathic Pulmonary Fibrosis ,Interstitial Lung Diseases ,Medical Director ,Clinical Lead ,Interstitial Lung Disease Unit ,Royal Brompton ,Project Management ,United Kingdom Brainomix ,Parkwalk Advisors ,Oxford University Innovation ,Chief Marketing ,Business Development ,Brainomix ,Health Care Amp Hospitals ,Artificial Intelligence ,Medical Pharmaceuticals ,Biotechnology ,Computer Amp Electronics ,Computer Software ,Pharmaceuticals ,Licensing ,